This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Translational Prostate Cancer
        • Women in Science
          Andrea Miyahira, Ph.D
        • Health Policy
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Education
      • Covid-19
      • The Prostate Cancer Foundation
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Pelvic Health & Reconstruction
      • Endourology
      • Testicular Cancer
      • Health Policy in Urological Diseases
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
    • Trials in Progress
      • DORA - PCCTC
      • IRONMAN - PCCTC
      • PROMISE - PCCTC
      • SPLASH Trial
      • Oral EPI-7386
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • SUO 2022
      • ASCO GU 2023
      • EAU 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology

Prostate Cancer

Recent Abstracts
Obstructive uropathy from locally advanced and metastatic prostate cancer: An old problem with new therapies - Abstract January 23, 2012
Environment as a potential key determinant of the continued increase of prostate cancer incidence in martinique - Abstract January 23, 2012
Controversy over treatment options in clinical T3 prostate cancer - Abstract January 23, 2012
Prostatectomy-pros and cons on open surgery/laparoscopic surgery/robot-assisted surgery - Abstract January 23, 2012
Castration-resistant prostate cancer: Where are we going? - Abstract January 23, 2012
A comparison of the impact of isotope ((125)I vs. (103)Pd) on toxicity and biochemical outcome after interstitial brachytherapy and external beam radiation therapy for clinically localized prostate cancer - Abstract January 23, 2012
Usefulness and predictive value of PSA density, adjusted by transition zone volume, in men with PSA levels between 2 and 4 ng/ml - Abstract January 23, 2012
NutriTRAILomics in prostate cancer: Time to have two strings to one's bow - Abstract January 23, 2012
Comparative analysis of three risk assessment tools in Australian patients with prostate cancer - Abstract January 20, 2012
Clinical results after high-dose intensity-modulated radiotherapy for high-risk prostate cancer - Abstract January 20, 2012
MR imaging of treated prostate cancer - Abstract January 20, 2012
Milk intake in early life and risk of advanced prostate cancer - Abstract January 20, 2012
Pros and cons of active surveillance for low-risk prostate cancer - Abstract January 20, 2012
Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer - Abstract January 20, 2012
Relation between prostate gland volume and some histological markers of malignancy - Abstract January 20, 2012
Integrating multiparametric prostate MRI into clinical practice - Abstract January 20, 2012
High-intensity focused ultrasound therapy for prostate cancer - Abstract January 19, 2012
Early experience in MRI-guided therapies of prostate cancer: HIFU, laser and photodynamic treatment - Abstract January 19, 2012
Prostate cancer: Localizing the cancer in patients with persistent negative biopsies - Abstract January 19, 2012
The role of Melancholia in prostate cancer patients' depression - Abstract January 19, 2012
Page 1176 of 1288
  • Start
  • Prev
  • 1171
  • 1172
  • 1173
  • 1174
  • 1175
  • 1176
  • 1177
  • 1178
  • 1179
  • 1180
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free